-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 07-12-2026 TO 07-18-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 06-21-2026 TO 06-27-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
-
Oncoinvent Reaches Key Milestone in Phase 2 Ovarian Cancer Trial for Radspherin®
A Significant Step Forward in Ovarian Cancer Research Oncoinvent AS, a clinical-stage radiopharmaceutical company, has announced a major achievement in its ongoing clinical development program. The company has officially reached the 50% recruitment milestone in its Phase 2a clinical trial evaluating Radspherin®, a novel alpha-emitting radioactive microsphere treatment designed for patients with advanced ovarian cancer.…
-
New Hope for IBD: Mabwell’s 9MW5211 Receives IND Clearance from NMPA
A Major Milestone in Gastrointestinal Research There is promising news for the inflammatory bowel disease (IBD) community. Mabwell (688062.SH), a leading innovative biopharmaceutical company, has officially announced that its proprietary drug candidate, 9MW5211, has received Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA) of China. Understanding 9MW5211 The clinical advancement of…
-
SGS Strengthens North American Bioanalytical Footprint with Acquisition of CMIC, Inc.
Strategic Expansion in Bioanalysis SGS, the world’s leading testing, inspection, and certification company, has officially announced a significant expansion of its North American operations. By acquiring CMIC, Inc., a specialized bioanalytical laboratory based in New Jersey, SGS is set to bolster its capabilities in the rapidly evolving pharmaceutical research sector. What This Means for the…
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 05-31-2026 TO 06-06-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
$BYSI, $CGEM, $CING, $CRDF, $CUE, $EQ, $VOR, 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 2026 Jefferies Global Healthcare Conference, biopharmaceutical, clinical-research, EULAR 2026 Congress (European Congress of Rheumatology), fda, new drug application, pr-newswire, press-releases, Webcast -
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
NYSEAMERICAN: $ATNM Source: Read More
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 05-24-2026 TO 05-30-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 05-17-2026 TO 05-23-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
$CGON, $CRBP, $FATE, $NBP, $NMRA, $TNXP, $VTGN, $ZNTL, A.G.P.’s Annual Virtual Healthcare Conference, biopharmaceutical, clinical-research, fda, H.C. Wainwright 4th Annual BioConnect Investor Conference, ISPOR 2026, new drug application, pr-newswire, press-releases, RBC Capital Markets Global Healthcare Conference, Stifel 2026 Virtual Oncology Forum -
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 05-03-2026 TO 05-09-2026
I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 03-01-2026 TO 03-07-2026
We’re excited to announce the release of our latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 02-22-2026 TO 02-28-2026
We’re excited to announce the release of our latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…
$ALDX, $ALXO, $BBIO, $CGEN, $FULC, $GANX, $IMRX, $TARA, $XNCR, ASCO Genitourinary Cancers Symposium, biopharmaceutical, clinical-research, fda, new drug application, Oppenheimer 36th Annual Healthcare Life Sciences Conference, pr-newswire, press-releases, Wells Fargo Executive Biotech Summit, World ADC London 2026 -
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 02-08-2026 TO 02-14-2026
Well well, The Seattle Seahawks take the Win in Super Bowl LX. This is what Google’s Gemini summarized regarding stock market prediction after the Win. And now, back to the BIO-TECH STOCK CATALYST REPORT. We’re excited to announce the release of our latest free bio tech stock catalyst report for the upcoming week. This new…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 02-01-2026 TO 02-07-2026
The Groundhog sees his shadow, so hunker down and trade more to warm up! 😉 We’re excited to announce the release of our latest bio tech stock catalyst report for the upcoming week. This new stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions…
$AMGN, $AZN, $BMY, $BSX, $DNLI, $GKOS, $GSK, $INCY, $JAZZ, $LLY, $MRNA, $PHVS, $REGN, $SNY, biopharmaceutical, clinical-research, fda, new drug application, pr-newswire, press-releases -
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 01-18-2026 TO 01-24-2026
We’re excited to announce the release of our latest bio tech stock catalyst report for the upcoming week. This new stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock quote page…
$ABBV, $AZN, $ELDN, $GMAB, $GNLX, $LLY, $LTRN, $MNKD, $NOV, $NVO, $NVS, $PFE, $SNY, biopharmaceutical, clinical-research, fda, new drug application, pr-newswire, press-releases -
NRx Pharmaceuticals Achieves Debt-Free Status Ahead of Drug Approvals
NASDAQ: $NRXP Summary of the Article/Press Release On December 18, 2025, NRx Pharmaceuticals, Inc. (Nasdaq: $NRXP), a clinical-stage biopharmaceutical company focused on treatments for central nervous system disorders like suicidal depression and PTSD, announced that it has fully eliminated its balance sheet debt. CEO Dr. Jonathan Javitt thanked Anson Funds for their support during tough…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF SEPTEMBER 28, 2025 – OCTOBER 04, 2025
September 28, 2025 EVENT EVENT DATE SYMBOL PRICE POTENTIAL % (+/-) OPEN INTEREST PRICE $ Clinical Trial 09/30/2025 AGEN 53.89 6,179 0.00 Clinical Trial 09/30/2025 BTAI 53.32 4,080 0.00 PDUFA 09/30/2025 FBIO 28.17 1,996 0.00 Clinical Trial 09/30/2025 ALEC 25.87 730 0.00 Clinical Trial 09/30/2025 STRO 44.79 170 0.00 Clinical Trial 09/30/2025 RCKT 34.65 2,506…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF FEBRUARY 2, 2025 – FEBRUARY 08, 2025
EVENT EVENT DATE SYMBOL PRICE POTENTIAL % (+/-) OPEN INTEREST PRICE $ Data Release 02/03/2025 IVVD 55.1 44 0.36 Conference 02/05/2025 ANAB 30.6 2,770 17.93 Conference 02/05/2025 CABA 22.5 12,509 2.39 Conference 02/05/2025 ABSI 23.2 14,305 3.71 Conference 02/06/2025 PRAX 33.6 13,932 76.55 Conference 02/06/2025 FBRX 23.4 504 15.89 Conference 02/06/2025 ADCT 32.3 172 1.68…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF JANUARY 26, 2025 – FEBRUARY 01, 2025
EVENT EVENT DATE SYMBOL PRICE POTENTIAL % (+/-) OPEN INTEREST PRICE $ Conference 01/28/2025 LXRX 49.9 4,606 0.99 Conference 01/28/2025 IPA 28.7 3,588 0.58 Webinar 01/29/2025 OTLK 21.0 1,839 1.99 Corporate Event 01/29/2025 ZNTL 58.3 4,312 2.22 FDA Event 01/30/2025 VRTX 17.34 48,375 439.62 FDA Event 01/31/2025 AXSM 13.99 45,376 103.11 Clinical Trial 02/01/2025 SUPN…